AustralieFrV1, PubMed, Corpus, bibRecord, 002104

Prospects for Moxidectin as a New Oral Treatment for Human Scabies.

Identifieur interne : 002104 ( PubMed/Corpus ); précédent : 002103; suivant : 002105

Prospects for Moxidectin as a New Oral Treatment for Human Scabies.

Auteurs : Kate E. Mounsey ; Charlotte Bernigaud ; Olivier Chosidow ; James S. Mccarthy

Source :

PLoS neglected tropical diseases [ 1935-2735 ] ; 2016.

RBID : pubmed:26985995

English descriptors

KwdEn :
- Acaricides (therapeutic use), Administration, Oral, Animals, Clinical Trials as Topic, Disease Models, Animal, Drug Evaluation, Preclinical, Drug Repositioning, Humans, Macrolides (therapeutic use), Scabies (drug therapy).
MESH :
- chemical , therapeutic use : Acaricides, Macrolides.
- drug therapy : Scabies.
- Administration, Oral, Animals, Clinical Trials as Topic, Disease Models, Animal, Drug Evaluation, Preclinical, Drug Repositioning, Humans.

DOI: 10.1371/journal.pntd.0004389
PubMed: 26985995

Links to Exploration step

pubmed:26985995

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Prospects for Moxidectin as a New Oral Treatment for Human Scabies.</title>
<author><name sortKey="Mounsey, Kate E" sort="Mounsey, Kate E" uniqKey="Mounsey K" first="Kate E" last="Mounsey">Kate E. Mounsey</name>
<affiliation><nlm:affiliation>Inflammation & Healing Research Cluster, School of Health and Sport Sciences, University of the Sunshine Coast, Maroochydore, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bernigaud, Charlotte" sort="Bernigaud, Charlotte" uniqKey="Bernigaud C" first="Charlotte" last="Bernigaud">Charlotte Bernigaud</name>
<affiliation><nlm:affiliation>Dermatology Department, Henri Mondor Hospital, AP-HP, UPEC, Créteil, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chosidow, Olivier" sort="Chosidow, Olivier" uniqKey="Chosidow O" first="Olivier" last="Chosidow">Olivier Chosidow</name>
<affiliation><nlm:affiliation>Dermatology Department, Henri Mondor Hospital, AP-HP, UPEC, Créteil, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mccarthy, James S" sort="Mccarthy, James S" uniqKey="Mccarthy J" first="James S" last="Mccarthy">James S. Mccarthy</name>
<affiliation><nlm:affiliation>Infectious Diseases & Immunology Division, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:26985995</idno>
<idno type="pmid">26985995</idno>
<idno type="doi">10.1371/journal.pntd.0004389</idno>
<idno type="wicri:Area/PubMed/Corpus">002104</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002104</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Prospects for Moxidectin as a New Oral Treatment for Human Scabies.</title>
<author><name sortKey="Mounsey, Kate E" sort="Mounsey, Kate E" uniqKey="Mounsey K" first="Kate E" last="Mounsey">Kate E. Mounsey</name>
<affiliation><nlm:affiliation>Inflammation & Healing Research Cluster, School of Health and Sport Sciences, University of the Sunshine Coast, Maroochydore, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Bernigaud, Charlotte" sort="Bernigaud, Charlotte" uniqKey="Bernigaud C" first="Charlotte" last="Bernigaud">Charlotte Bernigaud</name>
<affiliation><nlm:affiliation>Dermatology Department, Henri Mondor Hospital, AP-HP, UPEC, Créteil, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Chosidow, Olivier" sort="Chosidow, Olivier" uniqKey="Chosidow O" first="Olivier" last="Chosidow">Olivier Chosidow</name>
<affiliation><nlm:affiliation>Dermatology Department, Henri Mondor Hospital, AP-HP, UPEC, Créteil, France.</nlm:affiliation>
</affiliation>
</author>
<author><name sortKey="Mccarthy, James S" sort="Mccarthy, James S" uniqKey="Mccarthy J" first="James S" last="Mccarthy">James S. Mccarthy</name>
<affiliation><nlm:affiliation>Infectious Diseases & Immunology Division, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.</nlm:affiliation>
</affiliation>
</author>
</analytic>
<series><title level="j">PLoS neglected tropical diseases</title>
<idno type="eISSN">1935-2735</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Acaricides (therapeutic use)</term>
<term>Administration, Oral</term>
<term>Animals</term>
<term>Clinical Trials as Topic</term>
<term>Disease Models, Animal</term>
<term>Drug Evaluation, Preclinical</term>
<term>Drug Repositioning</term>
<term>Humans</term>
<term>Macrolides (therapeutic use)</term>
<term>Scabies (drug therapy)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Acaricides</term>
<term>Macrolides</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Scabies</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Administration, Oral</term>
<term>Animals</term>
<term>Clinical Trials as Topic</term>
<term>Disease Models, Animal</term>
<term>Drug Evaluation, Preclinical</term>
<term>Drug Repositioning</term>
<term>Humans</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26985995</PMID>
<DateCreated><Year>2016</Year>
<Month>03</Month>
<Day>18</Day>
</DateCreated>
<DateCompleted><Year>2016</Year>
<Month>07</Month>
<Day>22</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>02</Month>
<Day>20</Day>
</DateRevised>
<Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1935-2735</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>10</Volume>
<Issue>3</Issue>
<PubDate><Year>2016</Year>
<Month>Mar</Month>
</PubDate>
</JournalIssue>
<Title>PLoS neglected tropical diseases</Title>
<ISOAbbreviation>PLoS Negl Trop Dis</ISOAbbreviation>
</Journal>
<ArticleTitle>Prospects for Moxidectin as a New Oral Treatment for Human Scabies.</ArticleTitle>
<Pagination><MedlinePgn>e0004389</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pntd.0004389</ELocationID>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Mounsey</LastName>
<ForeName>Kate E</ForeName>
<Initials>KE</Initials>
<AffiliationInfo><Affiliation>Inflammation & Healing Research Cluster, School of Health and Sport Sciences, University of the Sunshine Coast, Maroochydore, Queensland, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Infectious Diseases & Immunology Division, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bernigaud</LastName>
<ForeName>Charlotte</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Dermatology Department, Henri Mondor Hospital, AP-HP, UPEC, Créteil, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chosidow</LastName>
<ForeName>Olivier</ForeName>
<Initials>O</Initials>
<AffiliationInfo><Affiliation>Dermatology Department, Henri Mondor Hospital, AP-HP, UPEC, Créteil, France.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Université Paris-est Créteil Val de Marne, Créteil, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>McCarthy</LastName>
<ForeName>James S</ForeName>
<Initials>JS</Initials>
<AffiliationInfo><Affiliation>Infectious Diseases & Immunology Division, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>School of Medicine, University of Queensland, Herston, Queensland, Australia.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2016</Year>
<Month>03</Month>
<Day>17</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>PLoS Negl Trop Dis</MedlineTA>
<NlmUniqueID>101291488</NlmUniqueID>
<ISSNLinking>1935-2727</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D056810">Acaricides</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D018942">Macrolides</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>51570-36-6</RegistryNumber>
<NameOfSubstance UI="C027837">milbemycin</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2015 Mar;9(3):e0003498</RefSource>
<PMID Version="1">25730203</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2014 May;8(5):e2872</RefSource>
<PMID Version="1">24854034</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2010 Jul;83(1):28-32</RefSource>
<PMID Version="1">20595473</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2010 Mar 11;362(10):896-905</RefSource>
<PMID Version="1">20220184</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Acta Trop. 2012 Jan;121(1):34-43</RefSource>
<PMID Version="1">22019935</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Dermatol. 2002 Dec;138(12):1618-9</RefSource>
<PMID Version="1">12472363</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trop Med Parasitol. 1993 Dec;44(4):331-2</RefSource>
<PMID Version="1">8134777</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2015 Oct;9(10):e0004151</RefSource>
<PMID Version="1">26516764</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2014 Jul 24;8(7):e2865</RefSource>
<PMID Version="1">25058013</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Med J Aust. 1994 Aug 1;161(3):232</RefSource>
<PMID Version="1">8080547</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2009;3(1):e354</RefSource>
<PMID Version="1">19125173</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Dermatol. 2009 Jul;145(7):840-1</RefSource>
<PMID Version="1">19620572</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Clin Infect Dis. 2004 Jul 1;39(1):e8-12</RefSource>
<PMID Version="1">15206075</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Nippon Med Sch. 2014;81(3):157-63</RefSource>
<PMID Version="1">24998962</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Vet Rec. 2011 Dec 10;169(24):637</RefSource>
<PMID Version="1">21979442</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Vet Parasitol. 1993 Dec;51(1-2):113-21</RefSource>
<PMID Version="1">8128574</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Am J Trop Med Hyg. 2008 Dec;79(6):856-63</RefSource>
<PMID Version="1">19052293</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2012 Nov;367(18):1750-2</RefSource>
<PMID Version="1">23113487</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Vet Parasitol. 2001 Dec 3;102(1-2):143-50</RefSource>
<PMID Version="1">11705660</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Vet Parasitol. 2000 Jan;87(2-3):207-16</RefSource>
<PMID Version="1">10622612</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet. 2012 Dec 15;380(9859):2197-223</RefSource>
<PMID Version="1">23245608</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Vet Pharmacol Ther. 2001 Apr;24(2):99-104</RefSource>
<PMID Version="1">11442783</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Pharmacol. 2003 Oct;43(10):1108-15</RefSource>
<PMID Version="1">14517193</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2009;3(11):e554</RefSource>
<PMID Version="1">19936297</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2006 Apr 20;354(16):1718-27</RefSource>
<PMID Version="1">16625010</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 2005 Jan;83(1):34-42</RefSource>
<PMID Version="1">15682247</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Parasitol Drugs Drug Resist. 2012 Apr 14;2:134-53</RefSource>
<PMID Version="1">24533275</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Dermatol. 2014 Jun;53(6):739-45</RefSource>
<PMID Version="1">24168177</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Br J Dermatol. 2015 Apr;172(4):1103-10</RefSource>
<PMID Version="1">25228137</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Dermatol. 2013 Sep;40(9):776-7</RefSource>
<PMID Version="1">23855317</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Epidemiol Infect. 2015 May;143(7):1542-51</RefSource>
<PMID Version="1">25195595</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2010;4(7):e756</RefSource>
<PMID Version="1">20668508</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Antimicrob Agents Chemother. 2011 Nov;55(11):5200-4</RefSource>
<PMID Version="1">21896908</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 2009 Jun;87(6):424-30</RefSource>
<PMID Version="1">19565120</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Trop Med Int Health. 2003 Dec;8(12):1093-101</RefSource>
<PMID Version="1">14641844</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2009;3(5):e444</RefSource>
<PMID Version="1">19478832</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Drugs Dermatol. 2014 Mar;13(3):316-23</RefSource>
<PMID Version="1">24595578</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2014 Jun;8(6):e2953</RefSource>
<PMID Version="1">24968000</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Bull World Health Organ. 2008 Apr;86(4):275-81</RefSource>
<PMID Version="1">18438516</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>PLoS Negl Trop Dis. 2013;7(8):e2167</RefSource>
<PMID Version="1">23951369</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Parasitology. 2014 May;141(6):725-32</RefSource>
<PMID Version="1">24476932</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Cochrane Database Syst Rev. 2007;(3):CD000320</RefSource>
<PMID Version="1">17636630</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Vet Pharmacol Ther. 2000 Apr;23(2):111-2</RefSource>
<PMID Version="1">10849257</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arch Dermatol. 1999 Jun;135(6):651-5</RefSource>
<PMID Version="1">10376691</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2010 Feb 25;362(8):717-25</RefSource>
<PMID Version="1">20181973</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lancet Infect Dis. 2015 Aug;15(8):960-7</RefSource>
<PMID Version="1">26088526</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>N Engl J Med. 2012 Nov;367(18):1687-93</RefSource>
<PMID Version="1">23113480</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D056810" MajorTopicYN="N">Acaricides</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000284" MajorTopicYN="N">Administration, Oral</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002986" MajorTopicYN="N">Clinical Trials as Topic</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004353" MajorTopicYN="N">Drug Evaluation, Preclinical</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058492" MajorTopicYN="N">Drug Repositioning</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018942" MajorTopicYN="N">Macrolides</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="Y">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012532" MajorTopicYN="N">Scabies</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4795782</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>3</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>3</Month>
<Day>18</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>7</Month>
<Day>23</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">26985995</ArticleId>
<ArticleId IdType="doi">10.1371/journal.pntd.0004389</ArticleId>
<ArticleId IdType="pii">PNTD-D-15-01677</ArticleId>
<ArticleId IdType="pmc">PMC4795782</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Corpus

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002104 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 002104 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Asie
   |area=    AustralieFrV1
   |flux=    PubMed
   |étape=   Corpus
   |type=    RBID
   |clé=     pubmed:26985995
   |texte=   Prospects for Moxidectin as a New Oral Treatment for Human Scabies.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i   -Sk "pubmed:26985995" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd   \
       | NlmPubMed2Wicri -a AustralieFrV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024

	Serveur d'exploration sur les relations entre la France et l'Australie
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur les relations entre la France et l'Australie

Prospects for Moxidectin as a New Oral Treatment for Human Scabies.

Prospects for Moxidectin as a New Oral Treatment for Human Scabies.

Source :

English descriptors

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki